drugset / Trial / NCT05711940
Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Efficacy, Safety, and Tolerability of two administrations of COMP360 in participants with treatment-resistant depression (TRD)
Timeline
- Start
- 2023-02-14
- Primary completion
- 2026-02
- Completion
- 2026-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Psilocybin | Other / unclassified | 1 mg | — |
| Subject | Psilocybin | Other / unclassified | 10 mg | — |
| Subject | Psilocybin | Other / unclassified | 25 mg | — |
Indications
No indication recorded.